Explore
Validate
Learn
Western blot
ImmunoprecipitationAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN967987 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-General Transcription Factor IIB (GTF2B) (AA 2-155) antibody
- Antibody type
- Monoclonal
- Antigen
- Human TFIIB
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- 24
- Vial size
- 50 µg
- Concentration
- 250 µg/ml
- Storage
- Store undiluted at -20° C.
Submitted references Regulation of beta-catenin function by the IkappaB kinases.
A functional interaction between the survival motor neuron complex and RNA polymerase II.
Solution structure of the C-terminal core domain of human TFIIB: similarity to cyclin A and interaction with TATA-binding protein.
Sequence of general transcription factor TFIIB and relationships to other initiation factors.
Lamberti C, Lin KM, Yamamoto Y, Verma U, Verma IM, Byers S, Gaynor RB
The Journal of biological chemistry 2001 Nov 9;276(45):42276-86
The Journal of biological chemistry 2001 Nov 9;276(45):42276-86
A functional interaction between the survival motor neuron complex and RNA polymerase II.
Pellizzoni L, Charroux B, Rappsilber J, Mann M, Dreyfuss G
The Journal of cell biology 2001 Jan 8;152(1):75-85
The Journal of cell biology 2001 Jan 8;152(1):75-85
Solution structure of the C-terminal core domain of human TFIIB: similarity to cyclin A and interaction with TATA-binding protein.
Bagby S, Kim S, Maldonado E, Tong KI, Reinberg D, Ikura M
Cell 1995 Sep 8;82(5):857-67
Cell 1995 Sep 8;82(5):857-67
Sequence of general transcription factor TFIIB and relationships to other initiation factors.
Malik S, Hisatake K, Sumimoto H, Horikoshi M, Roeder RG
Proceedings of the National Academy of Sciences of the United States of America 1991 Nov 1;88(21):9553-7
Proceedings of the National Academy of Sciences of the United States of America 1991 Nov 1;88(21):9553-7
No comments: Submit comment
No validations: Submit validation data